APA (7th ed.) Citation

Swart, E., Munshi, K., Peasah, S., Huang, Y., Nguyen, J., Henderson, R., & Good, C. (2022). HSD61 Trends in Utilization and Costs for Migraine Prophylaxis and Treatment in the United States, 2017-2020. Value in Health, 25(7), S490. https://doi.org/10.1016/j.jval.2022.04.1062

Chicago Style (17th ed.) Citation

Swart, E., K. Munshi, SK Peasah, Y. Huang, J. Nguyen, R. Henderson, and CB Good. "HSD61 Trends in Utilization and Costs for Migraine Prophylaxis and Treatment in the United States, 2017-2020." Value in Health 25, no. 7 (2022): S490. https://doi.org/10.1016/j.jval.2022.04.1062.

MLA (9th ed.) Citation

Swart, E., et al. "HSD61 Trends in Utilization and Costs for Migraine Prophylaxis and Treatment in the United States, 2017-2020." Value in Health, vol. 25, no. 7, 2022, p. S490, https://doi.org/10.1016/j.jval.2022.04.1062.